CRP and breast cancer: A cohort study comprising 17 402 Chinese females showed that women with high CRP levels (>3000 ng/mL) at baseline had a significantly higher breast cancer risk (adjusted RR = 1.80; 95% CI = 1.03, 3.15) than women with low CRP levels (<1000 ng/mL)52.